VANDA PHARMACEUTICALS INC (VNDA) Stock Income Statement
NASDAQ:VNDA • US9216591084
Current stock price
8.55 USD
-0.26 (-2.95%)
Last:
| 2025 (2025-12-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 216.10M | 198.77M | 192.64M | 254.40M | 268.70M | |||
| Cost Of Goods | 13.04M | 11.31M | 14.80M | 24.30M | 25.60M | |||
| Gross Profit | 203.06M | 187.46M | 177.84M | 230.10M | 243.10M | |||
| Operating Expenses | 354.23M | 228.12M | 191.80M | 223.80M | 181.10M | |||
| Research and Development | 109.27M | 74.43M | 76.82M | 85.80M | 55.60M | |||
| Selling, General, and Administrative Expenses | 237.95M | 146.41M | 112.88M | 136.50M | 124.00M | |||
| Operating Income | -151.17M | -40.66M | -13.95M | 6.30M | 62.00M | |||
| Other Income/Expense | 12.52M | 17.74M | 20.29M | 5.00M | 200.00K | |||
| Non Recurring Items | N/A | N/A | N/A | N/A | -19.80M | |||
| Income Before Taxes | -138.65M | -22.92M | 6.34M | 11.30M | 42.40M | |||
| Income Tax | 81.83M | -4.02M | 3.83M | 5.00M | 9.20M | |||
| Net Income | -220.47M | -18.90M | 2.51M | 6.30M | 33.20M | |||
| EBITDA | -140.95M | -32.53M | -10.94M | 9.00M | 64.90M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -3.74 | -0.33 | 0.04 | 0.11 | 0.58 | |||
| Non GAAP EPS | -1.80 | -0.32 | 0.05 | 0.12 | 0.58 | |||
| Statistics | ||||||||
| Gross Profit Margin | 93.96% | 94.31% | 92.32% | 90.45% | 90.47% | |||
| Profit Margin | -102.02% | -9.51% | 1.30% | 2.48% | 12.36% | |||
| Operating Profit Margin | -69.95% | -20.46% | -7.24% | 2.48% | 23.07% | |||
All data in USD